Regression of coronary plaque after coronary artery bypass graft

Yuhei Shiga1, Shin-Ichiro Miura1, Hiroaki Nishikawa1

  • 1Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.

Journal of Cardiology Cases
|December 12, 2018
PubMed

Insights

Lipid-lowering statin therapy may stabilize soft coronary artery plaque, as shown by multidetector computed tomography (MDCT). MDCT is valuable for diagnosing coronary artery disease and assessing plaque characteristics.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Sudden chest pain in a 62-year-old woman indicated potential coronary artery disease.
  • Severe stenosis of the left main coronary trunk artery (LMT) was suspected.
  • Plaque characteristics are crucial for assessing cardiovascular risk.

Purpose of the Study:

  • To evaluate the effectiveness of lipid-lowering therapy on coronary plaque stabilization.
  • To assess the utility of 64-multidetector row computed tomography (MDCT) in diagnosing and monitoring coronary artery disease.
  • To analyze changes in plaque density and stenosis severity over time.

Main Methods:

  • A 62-year-old female patient presenting with chest pain underwent 64-MDCT and coronary angiography (CAG).
  • Initial assessment revealed severe LMT stenosis with soft plaque (32.4 HU).
  • Treatment included statin therapy and coronary artery bypass graft (CABG). Follow-up assessments were performed after three years.

Main Results:

  • Initial 64-MDCT showed severe LMT stenosis with soft plaque.
  • After three years of statin therapy and CABG, follow-up 64-MDCT indicated mild stenosis and plaque regression (73.1 HU, intermediate plaque).
  • CAG revealed degradation of CABG flow and mild LMT stenosis.

Conclusions:

  • Lipid-lowering therapy with statins may contribute to the stabilization of soft coronary plaque.
  • Non-invasive 64-MDCT is a valuable tool for diagnosing coronary artery disease.
  • MDCT aids in evaluating coronary plaque size and properties, facilitating treatment monitoring.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.2K